Biotech

All Articles

GSK's long-acting bronchial asthma drug halved strikes in stage 3

.GSK's long-acting bronchial asthma treatment has been revealed to halve the number of assaults in a...

AstraZeneca, Daiichi unload Dato-DXd's total survival fail

.AstraZeneca as well as Daiichi Sankyo's TROP2-directed antibody-drug conjugate (ADC) has stopped wo...

Roivant introduces brand new 'vant' to accelerate Bayer hypertension med

.Matt Gline is back along with a brand-new 'vant' firm, after the Roivant Sciences chief executive o...

Viridian eye health condition phase 3 smash hits, evolving push to competing Amgen

.Viridian Therapies' stage 3 thyroid eye disease (TED) scientific trial has struck its key and subse...

Bain reveals $3B fund forever science providers

.Along with a powerful track record for pinpointing diamonds in the rough, Bain Funds Daily Life Sci...

Genentech's cancer restructure created 'for clinical causes'

.The current selection to combine Genentech's 2 cancer departments was made for "medical reasons," e...

Tern dental GLP-1 presents 5% effective weight loss at 1 month at best dose

.Terns Pharmaceuticals' decision to lose its liver disease aspirations might yet settle, after the b...

Merck, Daiichi replay early effectiveness in small mobile lung cancer along with updated ADC information

.Merck &amp Co.'s long-running initiative to land a punch on tiny mobile lung cancer cells (SCLC) ha...

Boehringer, Bayer advancement bronchi cancer cells medications towards Astra struggle

.Some clients along with non-small cell lung cancer (NSCLC) have anomalies in a genetics named indiv...

MBX tries for $136M IPO to take opponent to Ascendis in to stage 3

.MBX has elaborated plannings to take in over $136 thousand coming from its IPO as the biotech seeks...